Practice Point® CME Podcasts: Expert Discussions in Oncology™
Claim This Podcastby Practice Point Communications
Podcast Authority
Beta
Podcast Overview
<p>Join leading experts in the field of oncology as they explore the latest advancements, trends, and challenges in cancer care. From cutting-edge treatments and clinical trials to the human stories behind the science, each episode delves deep into the evolving landscape of oncology. If you’re seeking AMA, ABS, ANCC, or ACPE credit, these podcasts offer valuable knowledge, expert perspectives, and real-world insights to help you better understand cancer and its impact on individuals and society.</p>
Language
🇺🇲
Publishing Since
1/19/2025
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
BetaRecommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Reach the team behind Practice Point® CME Podcasts: Expert Discussions in Oncology™
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
January 19, 2025
Episode 14 - Talking TNBC: Advancing Treatment in Triple Negative Breast Cancer: Latest Insights and Clinical Strategies - Part 3
<p>Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers. It affects younger women, women of African descent, and those with BRCA1 mutations. TNBC is highly complex, with distinct subtypes that may respond differently to treatments. Recent advancements include immunotherapies, androgen receptor inhibitors, platinum-based drugs, antibody-drug conjugates, PARP inhibitors, and combination therapies. These podcast episodes address educational gaps in TNBC management, offering interactive cases, discussions on emerging treatments, and strategies to improve patient outcomes.</p><p></p><p>Launch Date: December 5, 2024</p><p>Release Date: December 5, 2024</p><p>Expiration Date: November 30, 2025</p><p></p><p>FACULTY</p><p><strong>Aditya Bardia, MD, MPH, FASCO</strong></p><p>Associate Professor, Medicine, Harvard Medical School</p><p>Attending Physician, Medical Oncology, Massachusetts General Hospital</p><p>Dana-Farber/Harvard Cancer Center, Boston, MA</p><p><strong>Rita Nanda, MD</strong></p><p>Associate Professor of Medicine</p><p>Director, Breast Oncology Program</p><p>The University of Chicago Medicine Chicago, IL</p><p></p><p>his podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.</p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.practicepointcme.com/CMEHome/talking-tnbc-advancing-treatment-in-triple-negative-breast-cancer-latest-insights-and-clinical-strategies-19">https://www.practicepointcme.com/CMEHome/talking-tnbc-advancing-treatment-in-triple-negative-breast-cancer-latest-insights-and-clinical-strategies-19</a></p>
January 19, 2025
Episode 13- Talking TNBC: Advancing Treatment in Triple Negative Breast Cancer: Latest Insights and Clinical Strategies - Part 2
<p>Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers. It affects younger women, women of African descent, and those with BRCA1 mutations. TNBC is highly complex, with distinct subtypes that may respond differently to treatments. Recent advancements include immunotherapies, androgen receptor inhibitors, platinum-based drugs, antibody-drug conjugates, PARP inhibitors, and combination therapies. These podcast episodes address educational gaps in TNBC management, offering interactive cases, discussions on emerging treatments, and strategies to improve patient outcomes.</p><p></p><p>Launch Date: December 5, 2024</p><p>Release Date: December 5, 2024</p><p>Expiration Date: November 30, 2025</p><p></p><p>FACULTY</p><p><strong>Aditya Bardia, MD, MPH, FASCO</strong></p><p>Associate Professor, Medicine, Harvard Medical School</p><p>Attending Physician, Medical Oncology, Massachusetts General Hospital</p><p>Dana-Farber/Harvard Cancer Center, Boston, MA</p><p><strong>Rita Nanda, MD</strong></p><p>Associate Professor of Medicine</p><p>Director, Breast Oncology Program</p><p>The University of Chicago Medicine Chicago, IL</p><p></p><p>his podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.</p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.practicepointcme.com/CMEHome/talking-tnbc-advancing-treatment-in-triple-negative-breast-cancer-latest-insights-and-clinical-strategies-19">https://www.practicepointcme.com/CMEHome/talking-tnbc-advancing-treatment-in-triple-negative-breast-cancer-latest-insights-and-clinical-strategies-19</a></p>
January 19, 2025
Episode 12 - Talking TNBC: Advancing Treatment in Triple Negative Breast Cancer: Latest Insights and Clinical Strategies - Part 1
<p>Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers. It affects younger women, women of African descent, and those with BRCA1 mutations. TNBC is highly complex, with distinct subtypes that may respond differently to treatments. Recent advancements include immunotherapies, androgen receptor inhibitors, platinum-based drugs, antibody-drug conjugates, PARP inhibitors, and combination therapies. These podcast episodes address educational gaps in TNBC management, offering interactive cases, discussions on emerging treatments, and strategies to improve patient outcomes.</p><p></p><p>Launch Date: December 5, 2024</p><p>Release Date: December 5, 2024</p><p>Expiration Date: November 30, 2025</p><p></p><p>FACULTY</p><p><strong>Aditya Bardia, MD, MPH, FASCO</strong></p><p>Associate Professor, Medicine, Harvard Medical School</p><p>Attending Physician, Medical Oncology, Massachusetts General Hospital</p><p>Dana-Farber/Harvard Cancer Center, Boston, MA</p><p><strong>Rita Nanda, MD</strong></p><p>Associate Professor of Medicine</p><p>Director, Breast Oncology Program</p><p>The University of Chicago Medicine Chicago, IL</p><p></p><p>his podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.</p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.practicepointcme.com/CMEHome/talking-tnbc-advancing-treatment-in-triple-negative-breast-cancer-latest-insights-and-clinical-strategies-19">https://www.practicepointcme.com/CMEHome/talking-tnbc-advancing-treatment-in-triple-negative-breast-cancer-latest-insights-and-clinical-strategies-19</a></p>
14 total episodes available
Deep-dive analytics for Practice Point® CME Podcasts: Expert Discussions in Oncology™
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Practice Point® CME Podcasts: Expert Discussions in Oncology™?
<p>Join leading experts in the field of oncology as they explore the latest advancements, trends, and challenges in cancer care. From cutting-edge treatments and clinical trials to the human stories behind the science, each episode delves deep into the evolving landscape of oncology. If you’re seeking AMA, ABS, ANCC, or ACPE credit, these podcasts offer valuable knowledge, expert perspectives, and real-world insights to help you better understand cancer and its impact on individuals and society.</p> - How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.